A game-changer for obesity and heart failure? Dr Pandey reveals breakthrough GLP-1 trial results that show reduced cardiovascular risk and better outcomes for HFpEF patients. Don’t miss this!

In terms of intangible assets, DaVita has built the largest network of dialysis clinics in the US over several decades, based in part on its brand and reputation for high-quality services, extensive ...

To maintain a healthy heart, researchers say people should focus on diet and exercise, limit alcohol, manage stress, get ...

Right now, our state’s most vulnerable populations that rely on Medicare and Medicaid are unable to access anti-obesity ...

Robert F. Kennedy Jr. said Thursday evening on Fox News that the “one place” he wants to see policies changed […] ...

Gold nanoparticles help lose fat more effectively than a common weight-loss drug, improving body fat levels and organ health ...

Childhood obesity rates are rising and global figures don't make for easy reading. The World Health Organization (WHO) ...

Diabetes UK reported that more than 12 million people in the UK are now living with diabetes or prediabetes. The total ...

Routine cleanings and check-ups are generally affordable, but the costs can rise significantly if your pet needs more ...

Scientists mapped fat tissue differences in obese individuals, uncovering cell changes linked to metabolic disease risk and ...

Shares of Hims & Hers Health, the telehealth provider that has found a niche in the obesity-drug boom, surged 28% on Thursday ...

As demand remains high for GLP-1 drugs, primary care physicians are concerned about the risks of patients using third-party ...